Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis ; volume:18 ; number:1 ; day:28 ; month:8 ; year:2019 ; pages:1-13 ; date:12.2019
Cardiovascular diabetology ; 18, Heft 1 (28.8.2019), 1-13, 12.2019
- Urheber
-
Fei, Yue
Tsoi, Man-Fung
Cheung, Bernard Man Yung
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-019-0916-z
- URN
-
urn:nbn:de:101:1-2020011021180968503669
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fei, Yue
- Tsoi, Man-Fung
- Cheung, Bernard Man Yung
- SpringerLink (Online service)
Ähnliche Objekte (12)
Comparative outcomes of heart failure among existent classes of anti-diabetic agents: a network meta-analysis of 171,253 participants from 91 randomized controlled trials
Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials
Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs
Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials of new antidiabetic drugs: a meta-analysis of digitalized individual patient data
Antidiabetic and cardiovascular beneficial effects of a liver-localized mitochondrial uncoupler
Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
Updates on cardiovascular outcome trials in diabetes
Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis
Influenza vaccination and major cardiovascular risk: a systematic review and meta-analysis of clinical trials studies
Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials
Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials
Effect of ivabradine on cardiovascular outcomes in patients with stable angina: meta-analysis of randomized clinical trials
Comparative outcomes of heart failure among existent classes of anti-diabetic agents: a network meta-analysis of 171,253 participants from 91 randomized controlled trials
Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials
Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs
Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials of new antidiabetic drugs: a meta-analysis of digitalized individual patient data
Antidiabetic and cardiovascular beneficial effects of a liver-localized mitochondrial uncoupler
Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
Updates on cardiovascular outcome trials in diabetes
Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis
Influenza vaccination and major cardiovascular risk: a systematic review and meta-analysis of clinical trials studies
Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials
Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials
Effect of ivabradine on cardiovascular outcomes in patients with stable angina: meta-analysis of randomized clinical trials
Comparative outcomes of heart failure among existent classes of anti-diabetic agents: a network meta-analysis of 171,253 participants from 91 randomized controlled trials
Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials
Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs
Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials of new antidiabetic drugs: a meta-analysis of digitalized individual patient data
Antidiabetic and cardiovascular beneficial effects of a liver-localized mitochondrial uncoupler
Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
Updates on cardiovascular outcome trials in diabetes
Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis
Influenza vaccination and major cardiovascular risk: a systematic review and meta-analysis of clinical trials studies
Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials
Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials